Downingtown, PA, United States of America

Daniel J Parks

USPTO Granted Patents = 19 

 

 

Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 24(Granted Patents)


Location History:

  • Exton, PA (US) (2006)
  • Downington, PA (US) (2014)
  • Downingtown, PA (US) (2006 - 2017)
  • Pepperell, MA (US) (2018 - 2023)

Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):

Title: The Innovative Contributions of Daniel J Parks

Introduction

Daniel J Parks is a notable inventor based in Downingtown, PA, with a remarkable portfolio of 18 patents. His work primarily focuses on advancements in pharmaceutical compounds and methods that address critical health conditions.

Latest Patents

Among his latest patents, Parks has developed compounds aimed at enhancing proteasome activity. These compounds are characterized by specific formulae and include pharmaceutically acceptable salts, solvates, clathrates, and prodrugs. His inventions also encompass methods for treating conditions associated with dysfunction in proteostasis. Additionally, he has disclosed compounds that modulate CFTR activity, addressing underlying defects in cellular processing.

Career Highlights

Parks has made significant contributions while working with prominent companies such as Janssen Pharmaceutica and Proteostasis Therapeutics, Inc. His expertise in the field has led to innovative solutions that have the potential to improve patient outcomes.

Collaborations

Throughout his career, Parks has collaborated with esteemed colleagues, including Mark R Player and Sanath K Meegalla, further enhancing the impact of his work in the pharmaceutical industry.

Conclusion

Daniel J Parks exemplifies the spirit of innovation through his extensive patent portfolio and contributions to pharmaceutical research. His work continues to influence the field and offers promising advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…